Hyperdopaminergia and altered locomotor activity in GABAB1‐deficient mice
Open Access
- 5 April 2006
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 97 (4) , 979-991
- https://doi.org/10.1111/j.1471-4159.2006.03806.x
Abstract
Mice, which are devoid of functional GABAB receptors, consistently exhibit marked hyperlocomotion when exposed to a novel environment. Telemetry recordings now revealed that, in a familiar environment, mice display an altered pattern of circadian activity but no hyperlocomotion. This indicates that hyperlocomotion is only triggered when mice are aroused by novelty. In microdialysis experiments, mice exhibited a 2‐fold increased extracellular level of dopamine in the striatum. Following d‐amphetamine administration, mice released less dopamine than wild‐type mice, indicative of a reduced cytoplasmic dopamine pool. The hyperdopaminergic state of mice is accompanied by molecular changes, including reduced levels of tyrosine hydroxylase mRNA, D1 receptor binding‐sites and Ser40 phosphorylation of tyrosine hydroxylase. Tyrosine hydroxylase activity, tissue dopamine content and dopamine metabolism do not appear to be measurably altered. Pharmacological and electrophysiological experiments support that the hyperdopaminergic state of mice is not severe enough to inactivate dopamine D2 receptors and to disrupt D2‐mediated feedback inhibition of tyrosine hydroxylase activity. The data support that loss of GABAB activity results in a sustained moderate hyperdopaminergic state, which is phenotypically revealed by contextual hyperlocomotor activity. Importantly, the presence of an inhibitory GABA tone on the dopaminergic system mediated by GABAB receptors provides an opportunity for therapeutic intervention.Keywords
This publication has 48 references indexed in Scilit:
- The GABAB Receptor-Positive Modulator GS39783 and the GABAB Receptor Agonist Baclofen Attenuate the Reward-Facilitating Effects of Cocaine: Intracranial Self-Stimulation Studies in the RatNeuropsychopharmacology, 2005
- GABAB Receptor Antagonist-Mediated Antidepressant-Like Behavior Is Serotonin-DependentThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Redistribution of GABAB(1)Protein and Atypical GABABResponses in GABAB(2)-Deficient MiceJournal of Neuroscience, 2004
- Bi-directional effects of GABAB receptor agonists on the mesolimbic dopamine systemNature Neuroscience, 2004
- Specific γ‐hydroxybutyrate‐binding sites but loss of pharmacological effects of γ‐hydroxybutyrate in GABAB(1)‐deficient miceEuropean Journal of Neuroscience, 2003
- Effects of GABA agonists on body temperature regulation in GABAB(1)−/− miceBritish Journal of Pharmacology, 2003
- Epilepsy, Hyperalgesia, Impaired Memory, and Loss of Pre- and Postsynaptic GABAB Responses in Mice Lacking GABAB(1)Neuron, 2001
- Epileptogenesis and Enhanced Prepulse Inhibition in GABAB1-Deficient MiceMolecular and Cellular Neuroscience, 2001
- Presynaptic modulation by dopamine and GABA opens a potassium channel in rat cortical, striatal and hippocampal synaptosomes via eicosanoidsNeurochemistry International, 1994
- Tissue-specific and high-level expression of the human tyrosine hydroxylase gene in transgenic miceNeuron, 1991